CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: A possible feedback mechanism in inflammation

Journal of Cell Science

Volumn 118, Issue 23, 2005, Pages 5625-5636

  Capra, Valérie ^a   Ravasi, Saula ^a   Accomazzo, Maria Rosa ^a   Citro, Simona ^a   Grimoldi, Monica ^a   Abbracchio, Maria P ^a   Rovati, G Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

CysLT1 receptor; Extracellular nucleotides; Heterologous desensitization; Inflammation; U937 cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; G PROTEIN COUPLED RECEPTOR KINASE 2; LEUKOTRIENE RECEPTOR; NUCLEOTIDE; PEPTIDOLEUKOTRIENE 1 RECEPTOR; PROTEIN KINASE C; PURINE P2Y RECEPTOR; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; CYCLOPEPTIDE; LEUKOTRIENE D4; LEUKOTRIENE D4 RECEPTOR; MEMBRANE PROTEIN; PACLITAXEL; PROTEIN KINASE; PURINE P2 RECEPTOR; YM 254890; YM-254890;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN COS7; CELL STRAIN U937; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR FLUID; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; SECOND MESSENGER;

ANIMALIA;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOTRIENE D4; MEMBRANE PROTEINS; NUCLEOTIDES; PACLITAXEL; PEPTIDES, CYCLIC; PROTEIN KINASES; RECEPTORS, LEUKOTRIENE; RECEPTORS, PURINERGIC P2; SECOND MESSENGER SYSTEMS; U937 CELLS; URIDINE DIPHOSPHATE;

EID: 30544447195     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02668     Document Type: Article

References (52)

1. Abbracchio, M. P. and Burnstock, G. (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther. 64, 445-475.
2. Abbracchio, M. P. and Burnstock, G. (1998). Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol. 78, 113-145.
3. Abbracchio, M. P., Boeynaems, J. M., Barnard, E. A., Boyer, J. L., Kennedy, C., Miras-Portugal, M. T., King, B. F., Gachet, C., Jacobson, K. A., Weisman, G. A. et al. (2003). Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci. 24, 52-55.
4. Accomazzo, M. R., Rovati, G. E., Vigano, T., Hernandez, A., Bonazzi, A., Bolla, M., Fumagalli, F., Viappiani, S., Galbiati, E., Ravasi, S. et al. (2001). Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent. Am. J. Respir. Crit. Care Med. 163, 266-272.
5. Adams, M. D., Celniker, S. E., Holt, R. A., Evans, C. A., Gocayne, J. D., Amanatides, P. G., Scherer, S. E., Li, P. W., Hoskins, R. A., Gatle, R. F. et al. (2000). The genome sequence of Drosophila melanogaster. Science 287, 2185-2195.
6. Ali, H., Richardson, R. M., Haribabu, B. and Snyderman, R. (1999). Chemoattractant receptor cross-desensitization. J. Biol. Chem. 274, 6027-6030.
7. Bouvier, M., Hausdorff, W. P., De Blasi, A., O'Dowd, B. F., Kobilka, B. K., Caron, M. G. and Lefkowitz, R. J. (1988). Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature 333, 370-373.
8. Brink, C., Dahlen, S. E., Drazen, J., Evans, J. F., Hay, D. W., Nicosia, S., Serhan, C. N., Shimizu, T. and Yokomizo, T. (2003). International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol. Rev. 55, 195-227.
9. Bunemann, M., Lee, K. B., Pals-Rylaarsdam, R., Roseberry, A. G. and Hosey, M. M. (1999). Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu. Rev. Physiol. 61, 169-192.
10. Capra, V. (2004). Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol. Res. 50, 1-11.
11. Capra, V., Bolla, M., Belloni, P. A., Mezzetti, M., Folco, G. C., Nicosia, S. and Rovati, G. E. (1998a). Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro. Br. J. Pharmacol. 123, 590-598.
12. Capra, V., Nicosia, S., Ragnini, D., Mezzetti, M., Keppler, D. and Rovati, G. E. (1998b). Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. Mol. Pharmacol. 53, 750-758.
13. Capra, V., Accomazzo, M. R., Ravasi, S., Parenti, M., Macchia, M., Nicosia, S. and Rovati, G. E. (2003). Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells. Prostaglandins Other Lipid Mediat. 71, 235-251.
14. Capra, V., Ravasi, S., Accomazzo, M. R., Parenti, M. and Rovati, G. E. (2004a). CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras. Biochem. Pharmacol. 67, 1569-1577.
15. Capra, V., Veltri, A., Foglia, C., Crimaldi, L., Habib, A., Parenti, M. and Rovati, G. E. (2004b). Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor: alternative role in G protein-coupled receptor signaling. Mol. Pharmacol. 66, 880-889.
16. Chuang, T. T., Iacovelli, L., Sallese, M. and De Blasi, A. (1996). G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17, 416-421.
17. Ciceri, P., Rabuffetti, M., Monopoli, A. and Nicosia, S. (2001). Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br. J. Pharmacol. 133, 1323-1329.
18. Citro, S., Ravasi, S., Rovati, G. E. and Capra, V. (2005). Thromboxane prostanoid receptor signals through Gi protein to rapidly activate ERK in human airways. Am. J. Respir. Cell Mol. Biol. 32, 326-333.
19. Communi, D., Janssens, R., Suarez-Huerta, N., Robaye, B. and Boeynaems, J. M. (2000). Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors. Cell Signal. 12, 351-360.
20. Cowen, D. S., Berger, M., Nuttle, L. and Dubyak, G. R. (1991). Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines. J. Leukoc. Biol. 50, 109-122.
21. Drazen, J. M. (2003). Leukotrienes in asthma. Adv. Exp. Med. Biol. 525, 1-5.
22. Ferguson, S. S. (2001). Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53, 1-24.
23. Fernandez, N., Monczor, F., Lemos, B., Notcovich, C., Baldi, A., Davio, C. and Shayo, C. (2002). Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation. Mol. Pharmacol. 62, 1506-1514.
24. Figueroa, D. J., Breyer, R. M., Defoe, S. K., Kargman, S., Daugherty, B. L., Waldburger, K., Liu, Q., Clements, M., Zeng, Z., O'Neill, G. P. et al. (2001). Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care Med. 163, 226-233.
25. Folco, G., Rossoni, G., Buccellati, C., Berti, F., Maclouf, J. and Sala, A. (2000). Leukotrienes in cardiovascular diseases. Am. J. Respir. Crit. Care Med. 161, S112-S116.
26. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G. and Schioth, H. B. (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272.
27. Frey, E. A., Nicholson, D. W. and Metters, K. M. (1993). Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung. Eur. J. Pharmacol. 244, 239-250.
28. Giovanazzi, S., Accomazzo, M. R., Letari, O., Oliva, D. and Nicosia, S. (1997). Internalization and down-regulation of the prostacyclin receptor in human platelets. Biochem. J. 325, 71-77.
29. Herold, C. L., Li, Q., Schachter, J. B., Harden, T. K. and Nicholas, R. A. (1997). Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7. Biochem. Biophys. Res. Commun. 235, 717-721.
30. Iino, M., Furugori, T., Mori, T., Moriyama, S., Fukuzawa, A. and Shibano, T. (2002). Rational design and evaluation of new lead compound structures for selective betaARK1 inhibitors. J. Med. Chem. 45, 2150-2159.
31. Jin, J., Dasari, V. R., Sistare, F. D. and Kunapuli, S. P. (1998). Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol. 123, 789-794.
32. Kanaoka, Y. and Boyce, J. A. (2004). Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173, 1503-1510.
33. Kunapuli, S. P. and Daniel, J. L. (1998). P2 receptor subtypes in the cardiovascular system. Biochem. J. 336, 513-523.
34. Lotzer, K., Spanbroek, R., Hildner, M., Urbach, A., Heller, R., Bretschneider, E., Galczenski, H., Evans, J. F. and Habenicht, A. J. (2003). Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 23, E32-E36.
35. Luttrell, L. M. and Lefkowitz, R. J. (2002). The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455-465.
36. 1 receptor. Nature 399, 789-793.
37. Mellor, E. A., Maekawa, A., Austen, K. F. and Boyce, J. A. (2001). Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc. Natl. Acad. Sci. USA 98, 7964-7969.
38. Miranda, M. B., McGuire, T. F. and Johnson, D. E. (2002). Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 16, 683-692.
39. Munson, P. J. and Rodbard, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
40. Naik, S., Billington, C. K., Pascual, R. M., Deshpande, D. A., Stefano, F. P., Kohout, T. A., Eckman, D. M., Benovic, J. L. and Penn, R. B. (2005). Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J. Biol. Chem. 280, 8722-8732.
41. Nicosia, S., Capra, V. and Rovati, G. E. (2001). Leukotrienes as mediators of asthma. Pulm. Pharmacol. Ther. 14, 3-19.
42. Porreca, E., Di Febbo, C., Di Sciullo, A., Angelucci, D., Nasuti, M., Vitullo, P., Reale, M., Conti, P., Cuccurullo, F. and Poggi, A. (1996). Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia. Thromb. Haemost. 76, 99-104.
43. Ravasi, S., Capra, V., Mezzetti, M., Nicosia, S. and Rovati, G. E. (2000). A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma. Mol. Pharmacol. 57, 1182-1189.
44. Ravasi, S., Capra, V., Panigalli, T., Rovati, G. E. and Nicosia, S. (2002). Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma. Biochem. Pharmacol. 63, 1537-1546.
45. Rovati, G. E. (1998). Ligand-binding studies: old beliefs and new strategies. Trends Pharmacol. Sci. 19, 365-369.
46. Sak, K., Boeynaems, J. M. and Everaus, H. (2003). Involvement of P2Y receptors in the differentiation of haematopoietic cells. J. Leukoc. Biol. 73, 442-447.
47. Samuelsson, B. (1983). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568-575.
48. Selbie, L. A. and Hill, S. J. (1998). G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol. Sci. 19, 87-93.
49. Takasaki, J., Saito, T., Taniguchi, M., Kawasaki, T., Moritani, Y., Hayashi, K. and Kobori, M. (2004). A novel Galphaq/11-selective inhibitor. J. Biol. Chem. 279, 47438-47445.
50. Vegesna, R. V., Wu, H. L., Mong, S. and Crooke, S. T. (1988). Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells. Mol. Pharmacol. 33, 537-542.
51. Winkler, J. D., Saran, H. M., Foley, J. J. and Crooke, S. T. (1988). Leukotriene D4-induced homologous desensitization in basal and differentiated U-937 cells: characterization with the partial agonist leukotriene E4 and assessment of receptor reserve. J. Pharmacol. Exp. Ther. 247, 54-62.
52. Zamah, A. M., Delahunty, M., Luttrell, L. M. and Lefkowitz, R. J. (2002). Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system. J Biol. Chem. 277, 31249-31256.